BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 24, 2025
Home » Topics » Analysis and data insight

Analysis and data insight
Analysis and data insight RSS Feed RSS

Blocks with gears, lightbulb, target, magnifying glass

EY Pulse: Strong recovery for med tech in 2021

Sep. 27, 2021
By Annette Boyle
Ernst and Young’s (EY) annual Pulse of the Industry report released today provided proof of med tech’s strong rebound from the disruption of the pandemic. Research and development investment soared, deal activity hit new highs, venture capital poured $9.1 billion into the sector, IPOs doubled, and more than 9 out of 10 of commercial leaders reported increased revenues.
Read More
ICYMI illustration

ICYMI: Week in review, Sept. 20-24, 2021

Sep. 27, 2021
A quick look back at top stories.
Read More

Money raised by biopharma: 2021 vs. 2020 vs. 2019

Sep. 24, 2021
Total raised in public, private and other financings of biopharma companies, comparing 2021 vs. 2020 vs. 2019.
Read More

Biopharma money raised: Jan. 1-Sept. 23, 2021

Sep. 24, 2021
Year-to-date money raised in public, private and other financings of biopharma companies.
Read More
Stock chart, upward arrow

Biggest gainers and losers for the week of Sept. 20-24, 2021

Sep. 24, 2021
The top 10 biopharma stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Sept. 20-24, 2021

Sep. 24, 2021
The top 10 med-tech stock gainers and losers for the week.
Read More

Black box warnings and risky CNS efforts weigh heavily on biopharma stocks

Sep. 23, 2021
By Karen Carey
For the first time since February, the BioWorld Biopharmaceutical Index (BBI) took a sharp plummet with shares falling in the last few weeks for 18 of the 22 stock components.
Read More
Handshake with digital globe overlay

Deals vie for the top with neuro, cancer therapies leading the way

Sep. 21, 2021
By Karen Carey
While 2020 is certainly a hard year to beat, 2021 has so far recorded a respectable amount of biopharma deals and is on track to exceed every other year. The number this year, including licensings, collaborations and joint ventures, is trailing 2020 by only 3%. BioWorld has recorded 1,447 deals valued at $131.75 billion in 2021 vs. 1,488 worth $141.56 billion last year. That puts 2021 about 7% behind 2020 on deal values.
Read More

Deals vie for the top with neuro, cancer therapies leading the way

Sep. 20, 2021
By Karen Carey
While 2020 is certainly a hard year to beat, 2021 has so far recorded a respectable amount of biopharma deals and is on track to exceed every other year.
Read More
ICYMI illustration

ICYMI: Week in review, Sept. 13-17, 2021

Sep. 20, 2021
A quick look back at top stories.
Read More
Previous 1 2 … 154 155 156 157 158 159 160 161 162 … 260 261 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 23, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 23, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 20, 2025
  • Drug capsule and dollar sign

    Little bite from voluntary most-favored nation Rx pricing order

    BioWorld
    After a week of hype, the most-favored nation (MFN) drug pricing executive order (EO) U.S. President Donald Trump signed May 12 has a lot of bark but little bite,...
  • Illustration of liver with DNA double helixes

    ASGCT 2025: Gene and cell therapies transform metabolic diseases

    BioWorld Science
    Metabolic disorders such as argininosuccinic and glutaric aciduria, methylmalonic acidemia, homocystinuria or primary hyperoxaluria require specific diets to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing